Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Stephen Ankier completed a PhD in pharmacology at the School of Pharmacy in London (1967) and then joined Allen & Hanbury’s where he directed a preclinical unit to evaluate novel compounds in the search for new medicines.
Daniel Anthony is Professor of Experimental Neuropathology in the Department of Pharmacology at the University of Oxford where he explores the contribution of inflammation to CNS injury and disease.
José-Antonio Arias-Montaño received his MD degree (1985) from Universidad Autónoma Metropolitana, Mexico City, and the PhD degree (Neurosciences, 1990) from Centre for Research and Advanced Studies (Cinvestav), also in Mexico City.
Mike Armstrong was awarded a BSc in Applied Biology by Bath University in 1967 and a PhD in Pharmacology by London University in 1975 while employed at the Wellcome Research Laboratories.
Maria Augusta Arruda holds a BSc.
Aisah Aubdool is a Lecturer in Cardiovascular Pharmacology at Queen Mary University of London.
Daren first trained in Theoretical Physics, before moving to Clinical Pharmacology by way of a Wellcome Trust Training Fellowship in Biomathematics.
David Back is Professor (Emeritus) of Pharmacology at the University of Liverpool and has been at the forefront of studies on Pharmacokinetics and drug–drug interactions of some key areas of drug therapy including oral contraceptives, anti-HIV drugs and drugs for treatment of Hepatitis C.
Alexis Bailey is a Reader in Neuropharmacology, currently Head of Pharmacology Section at St.
Dr Chris Bailey obtained his BSc and PhD in Pharmacology at the University of Bristol.